We are live on ! Find out more
WST icon

West Pharmaceutical
WST

197 hedge funds and large institutions have $2.19B invested in West Pharmaceutical in 2013 Q2 according to their latest regulatory filings, with 197 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

180.46% more ownership

Funds ownership: 0% → 180.46% (+180%)

Holders
197
Holders Change
+197
Holders Change %
–
% of All Funds
6.43%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
197
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Neuberger Berman Group
1
Neuberger Berman Group
New York
$188M +$176M +5,343,388 New
Franklin Resources
2
Franklin Resources
California
$173M +$162M +4,914,458 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$164M +$154M +4,666,236 New
BFA
4
BlackRock Fund Advisors
California
$117M +$110M +3,339,056 New
CIP
5
Champlain Investment Partners
Vermont
$78.1M +$73.1M +2,221,930 New
KI
6
Kalmar Investments
Delaware
$70.4M +$65.9M +2,003,092 New
BIT
7
BlackRock Institutional Trust
California
$66.1M +$61.9M +1,881,082 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$63.3M +$59.3M +1,800,540 New
BTW
9
Boston Trust Walden
Massachusetts
$57.1M +$53.5M +1,626,354 New
GIM
10
Granahan Investment Management
Massachusetts
$57.1M +$53.4M +1,624,100 New
DIA
11
Denver Investment Advisors
Colorado
$55.5M +$52M +1,579,336 New
State Street
12
State Street
Massachusetts
$55.4M +$51.9M +1,575,694 New
Fisher Asset Management
13
Fisher Asset Management
Washington
$46.3M +$43.4M +1,318,978 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$45.8M +$42.9M +1,303,068 New
Lord, Abbett & Co
15
Lord, Abbett & Co
New Jersey
$45.5M +$42.6M +1,295,400 New
Northern Trust
16
Northern Trust
Illinois
$42M +$39.3M +1,194,402 New
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$39.6M +$37.1M +1,126,396 New
RCG
18
Ruane, Cunniff & Goldfarb
New York
$39.4M +$36.9M +1,122,262 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$34.5M +$32.3M +982,920 New
SAM
20
Silvercrest Asset Management
New York
$31M +$29.1M +883,812 New
Invesco
21
Invesco
Georgia
$30.6M +$28.7M +871,954 New
HIM
22
Hermes Investment Management
United Kingdom
$30.5M +$28.6M +868,814 New
Ameriprise
23
Ameriprise
Minnesota
$29.3M +$27.4M +833,982 New
GKIM
24
GW&K Investment Management
Massachusetts
$28.6M +$26.8M +813,558 New
ICM
25
IronBridge Capital Management
Illinois
$27.7M +$25.9M +787,912 New
1
2 3 4 5

WST Hedge Fund Activity: Q2 2013 in Review

197 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2013, worth a combined $2.19B.

Buyers outnumbered sellers: 197 funds opened new WST positions and 0 closed out — a net gain of 197 holders — while 0 added to existing stakes and 0 trimmed.

  • 197 institutional investors held West Pharmaceutical (WST) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.19B of West Pharmaceutical stock for Q2 2013.
  • 197 funds opened new West Pharmaceutical positions in Q2 2013 and 0 closed out, a net change of +197 holders.

Based on aggregated 13F filings for Q2 2013.